THIS IS FOR MARKET RESEARCH PURPOSES ONLY, NOT A REQUEST FOR QUOTE OR SOLICITATION. The Food and Drug Administration, Jefferson Laboratories, in Jefferson, Arkansas, is seeking business sources, including service-disabled veteran-owned small businesses, HUBZone small businesses, and 8(a) certified companies. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort: The government is looking to pursue the production of a triple-transgenic, mutation assay C57B1/6 mouse containing the mutational target genes lacI, cII, gpt-delta, and ?X174. The FDA has already produced the ?X174/gpt-delta hybrid animals. The FDA is looking for potential sources that can provide a license agreement for the FDA to breed the transgenic mouse/rat that has as target genes lacI and cII with hybrid animals. Potential contractors must indicate business size and proof of any set-aside certification and provide a contact name, the mailing address, phone number and email address of point of contact. Capability statements must provide enough information to determine if the company can meet the requirement. Interested Contractors must respond with capability statements which are due in person, by postal mail, fax or email to the point of contact listed below on or before Monday March 31, 2008 by 14:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OSS/OFFAS, Attn: Nick Sartain, 3900 NCTR Road, HFT-320, Jefferson, AR 72079-9502. For information regarding this market survey, please contact Nick Sartain at (870) 543-7370, FAX (870) 543-7990 or email [email protected].

Bid Protests Not Available